Shail leads the Northern European hub of McKinsey’s Pharmaceuticals & Medical Products Practice. He also coleads the European Organization Practice and the firm’s cross-sector work on enterprise agility.
Since joining McKinsey, Shail has worked with organisations around the globe on driving innovation, productivity, and growth; supporting major postmerger integrations, carve outs, and asset transfers; leading important performance transformations and restructurings; launching numerous medical devices and pharmaceutical products; and bringing about commercial and product-development excellence.
Prior to joining McKinsey, Shail gained experience in research science, business development, and project finance.
Published work
“The impact of agility: How to shape your organization to compete,” McKinsey & Company, May 2021
“The journey to agile: How companies can become faster, more productive, and more responsive,” McKinsey & Company, October 2020
“The journey to an agile organization,” McKinsey & Company, May 2019
“Activate agility: the five avenues to success,” McKinsey & Company, February 2018
“Rethinking pharma productivity,” McKinsey & Company, January 2017
“Change lessons from pharma and med tech,” McKinsey & Company, May 2016
“Confronting change fatigue in the pharmaceutical industry,” McKinsey Quarterly, September 2014
Past Experience
PSEG Global
Manager, business development and financing
Education
Northwestern University, Kellogg School of Management
MBA
Oxford University
MSc. molecular and cellular biochemistry